Kaisa Health Group Holdings
Market Cap
HK$685.7m
Last Updated
2021/01/21 10:23 UTC
Data Sources
Company Financials
Executive Summary
Kaisa Health Group Holdings Limited, an investment holding company, manufactures and trades in dental prosthetics in the People’s Republic of China and internationally. More Details
Rewards
Risk Analysis
Snowflake Analysis
Flawless balance sheet and fair value.
Share Price & News
How has Kaisa Health Group Holdings's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: 876 is not significantly more volatile than the rest of Hong Kong stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: 876's weekly volatility (6%) has been stable over the past year.
Market Performance
7 Day Return
0%
876
6.2%
HK Medical Equipment
5.7%
HK Market
1 Year Return
-36.9%
876
102.3%
HK Medical Equipment
14.3%
HK Market
Return vs Industry: 876 underperformed the Hong Kong Medical Equipment industry which returned 102.3% over the past year.
Return vs Market: 876 underperformed the Hong Kong Market which returned 14.3% over the past year.
Shareholder returns
| 876 | Industry | Market | |
|---|---|---|---|
| 7 Day | 0% | 6.2% | 5.7% |
| 30 Day | 1.5% | 8.1% | 13.6% |
| 90 Day | 12.3% | 16.0% | 19.6% |
| 1 Year | -36.9%-36.9% | 105.7%102.3% | 18.9%14.3% |
| 3 Year | -58.5%-58.5% | 208.6%193.5% | -2.9%-13.1% |
| 5 Year | -63.0%-63.0% | 336.7%299.8% | 70.9%42.2% |
Long-Term Price Volatility Vs. Market
How volatile is Kaisa Health Group Holdings's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 months ago | Simply Wall St
Who Has Been Buying Kaisa Health Group Holdings Limited (HKG:876) Shares?4 months ago | Simply Wall St
A Look At Kaisa Health Group Holdings' (HKG:876) Share Price Returns6 months ago | Simply Wall St
Companies Like Kaisa Health Group Holdings (HKG:876) Are In A Position To Invest In GrowthValuation
Is Kaisa Health Group Holdings undervalued compared to its fair value and its price relative to the market?
>50%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: 876 (HK$0.14) is trading below our estimate of fair value (HK$0.69)
Significantly Below Fair Value: 876 is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: 876 is unprofitable, so we can't compare its PE Ratio to the HK Medical Equipment industry average.
PE vs Market: 876 is unprofitable, so we can't compare its PE Ratio to the Hong Kong market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate 876's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: 876 is good value based on its PB Ratio (1.1x) compared to the HK Medical Equipment industry average (3.9x).
Next Steps
Future Growth
How is Kaisa Health Group Holdings forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
34.8%
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Kaisa Health Group Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Next Steps
- Examine whether Kaisa Health Group Holdings is trading at an attractive price based on how much it is expected to earn in the future, and relative to its industry peers and the wider market.
- Kaisa Health Group Holdings competitive advantages and company strategy can generally be found in its financial reports archived here.
- Explore growth companies in the Healthcare industry.
Past Performance
How has Kaisa Health Group Holdings performed over the past 5 years?
-58.3%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 876 is currently unprofitable.
Growing Profit Margin: 876 is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: 876 is unprofitable, and losses have increased over the past 5 years at a rate of 58.3% per year.
Accelerating Growth: Unable to compare 876's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 876 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (17.7%).
Return on Equity
High ROE: 876 has a negative Return on Equity (-57.42%), as it is currently unprofitable.
Next Steps
Financial Health
How is Kaisa Health Group Holdings's financial position?
Financial Position Analysis
Short Term Liabilities: 876's short term assets (HK$368.5M) exceed its short term liabilities (HK$76.9M).
Long Term Liabilities: 876's short term assets (HK$368.5M) exceed its long term liabilities (HK$14.9M).
Debt to Equity History and Analysis
Debt Level: 876's debt to equity ratio (0%) is considered satisfactory.
Reducing Debt: 876's debt to equity ratio has reduced from 10.3% to 0% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable 876 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: 876 is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 9.4% per year.
Next Steps
Dividend
What is Kaisa Health Group Holdings's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate 876's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate 876's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if 876's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if 876's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: 876 is not paying a notable dividend for the Hong Kong market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of 876's dividend in 3 years as they are not forecast to pay a notable one for the Hong Kong market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
1.9yrs
Average management tenure
CEO
Jun Luo (40 yo)
1.92yrs
Tenure
HK$2,926,000
Compensation
Mr. Jun Luo serves as Chief Executive Officer and Co-Vice Chairman of the Board of Kaisa Health Group Holdings Limited since February 26, 2019. He was Vice President of Kaisa Group Holdings Ltd. Mr. Luo al...
CEO Compensation Analysis
Compensation vs Market: Jun's total compensation ($USD377.47K) is above average for companies of similar size in the Hong Kong market ($USD230.00K).
Compensation vs Earnings: Jun's compensation has increased whilst the company is unprofitable.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Vice Chairman of the Board & CEO | 1.92yrs | HK$2.93m | no data | |
| Co-Vice Chairman of the Board | 1.92yrs | HK$7.77m | 4.86% HK$ 33.3m | |
| Chief Operating Officer | 5.33yrs | no data | no data | |
| Executive Director | 1.92yrs | HK$84.00k | 6.15% HK$ 42.2m | |
| GM & Sales Director of Sub. of the Group | no data | no data | no data | |
| Executive Chairman | 0.75yr | no data | no data | |
| Company Secretary | 2.08yrs | no data | no data |
1.9yrs
Average Tenure
50yo
Average Age
Experienced Management: 876's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Vice Chairman of the Board & CEO | 1.92yrs | HK$2.93m | no data | |
| Co-Vice Chairman of the Board | 1.92yrs | HK$7.77m | 4.86% HK$ 33.3m | |
| Executive Director | 1.92yrs | HK$84.00k | 6.15% HK$ 42.2m | |
| Executive Chairman | 0.75yr | no data | no data | |
| Independent Non-Executive Director | 2.83yrs | HK$221.00k | no data | |
| Independent Non-Executive Director | 4yrs | HK$221.00k | no data | |
| Independent Non-Executive Director | 2.83yrs | HK$221.00k | no data |
1.9yrs
Average Tenure
56yo
Average Age
Experienced Board: 876's board of directors are not considered experienced ( 1.9 years average tenure), which suggests a new board.
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Kaisa Health Group Holdings Limited's company bio, employee growth, exchange listings and data sources
Key Information
- Name: Kaisa Health Group Holdings Limited
- Ticker: 876
- Exchange: SEHK
- Founded: 1971
- Industry: Health Care Supplies
- Sector: Healthcare
- Market Cap: HK$685.731m
- Shares outstanding: 5.04b
- Website: https://www.kaisahealth.com
Number of Employees
Location
- Kaisa Health Group Holdings Limited
- The Center
- 30th Floor
- Central
- Hong Kong
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| 876 | SEHK (The Stock Exchange of Hong Kong Ltd.) | Yes | Ordinary Shares | HK | HKD | Apr 1997 |
Biography
Kaisa Health Group Holdings Limited, an investment holding company, manufactures and trades in dental prosthetics in the People’s Republic of China and internationally. The company offers dental prosthetic...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2021/01/21 10:23 |
| End of Day Share Price | 2021/01/21 00:00 |
| Earnings | 2020/06/30 |
| Annual Earnings | 2019/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.